Axonics Inc (Axonics) is a medical technology company that is developing and commercializing novel products for adults with bladder and bowel dysfunction. The company offers rechargeable and recharge-free sacral neuromodulation systems (SNM) including Axonics F15 and R20 systems for treating overactive bladder, fecal incontinence and urinary retention. It also offers Bulkamid, a urethral bulking agent for female stress urinary incontinence. The company operates in France, the UK, Australia, Germany and the US. Axonics is headquartered in Irvine, California, the US.
Axonics Inc premium industry data and analytics
Products and Services
Products | Brands |
---|---|
Axonics F15 and R20 System: Treating Overactive Bladder, Fecal Incontinence and Urinary Retention | Axonics |
Bulkamid: Female Stress Urinary Incontinence |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
Year | Event | Description |
---|---|---|
2024 | Regulatory Approval | In March, the company secured approval from CE Mark for the Axonics R20 rechargeable sacral neuromodulation system. |
2024 | Contracts/Agreements | In January, the company signed an agreement to be acquired by Boston Scientific. |
2023 | Acquisitions/Mergers/Takeovers | In April, the company announced the acquisition of a lead placement solution from Radian, LLC. |
Competitor Comparison
Key Parameters | Axonics Inc | Medtronic Plc | Boston Scientific Corp | Allergan Ltd | Coloplast Corp |
---|---|---|---|---|---|
Headquarters | United States of America | Ireland | United States of America | Ireland | United States of America |
City | Irvine | Dublin | Marlborough | Dublin | Minneapolis |
State/Province | California | - | Massachusetts | Leinster | Minnesota |
No. of Employees | 797 | 95,000 | 48,000 | - | - |
Entity Type | Public | Public | Public | Private | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Michael H. Carrel | Chairman | Executive Board | 2019 | 52 |
Raymond W. Cohen | Director; Chief Executive Officer | Executive Board | 2013 | 64 |
Dan L. Dearen | Chief Financial Officer; President | Senior Management | 2018 | 60 |
Rinda Sama | Chief Operating Officer | Senior Management | 2018 | 44 |
Guangqiang Jiang | Chief Technology Officer | Senior Management | - | - |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward